This out from OTC Tip Reporter keep a close eye on this one. Explosive Catalyst (NWPN) Poised to Breakout as Congress
Introduces New Bill to Make Hemp and CBD Le·g·al as a Dietary Supplement
at a Federal level, Which Could Send Shares Soaring!
Dear Fellow Trader,
Immediately turn your attention to The Now Corporation (NWPN)
This is my next stock that looks ready to move in a major way, so make sure you have it pulled up on your trading screen Monday morning at the opening bell!
?A New Bill Introduced by Congress a few days ago, H.R.841 to make Hemp and CBD Le·g·al as a Dietary Supplement at a Federal level, could potentially send shares of NWPN soaring +520%.
Under the Radar CBD Pharma Player
Could Offer Major Upside...
NWPN has already made a +520% move since the beginning of 2021 and could be setting up for a much bigger move to the upside.
This is the kind of move that would have turned $2,000 into over $10,000 in less than 2 months. If you missed out on this, you need to hurry up and put (NWPN) on your watch list for Monday.
Keep reading to see why I am so excited about bringing you NWPN...
If you are a new member, we’d like to “Welcome You” and get you started in the right direction. We are letting you know (right now) to put NWPN on your watch list for the first thing Monday morning. This could be your chance to witness another potential +520% move.
Once again, for the new members who just joined us, welcome! For our loyal ones, a big Congrats on a string of big gainers. Let me remind you, we're coming off of recent alerts like (SPONF), that showed our members a multi-day gain of +547.05% in less than 72 hours, and it was up +1,150% from my alert at .0088 on Jan.19th.
Just to recap some of our recent alerts, and why you should be reading our reports:
(GTSIF): Alert Price $.131 2/18 – High $0.22 2/23 (+67.93% Gains)
(SPONF): Alert Price $.017 2/16 – High $0.11 2/19 (+547.05% Gains)
(FDCT): Alert Price $.47 2/1 - High $.945 2/10 (+101.06% Gains)
(AIKI): Alert Pre-Mkt $.84 1/6 – High $2.65 Pre-Mkt 2/16 (+215.47% Gains)
(SILO): Alert Price $.40 12/2 – High $0.59 12/14 (+47.49% Gains)
(UMAX): Alert Price $.39 1/11 – High $0.60 2/1 (+53.84% Gains)
You Need to Immediately Turn Your Attention to NWPN
Our next alert brings us down to the Fastest-Growing Medical Marijuana Market in the US. Florida.
Based out of Palm Beach, FL The Now Corporation (NWPN) is a bio-pharma research company focused on the research, education and production of Scientific-Grade Cannabidiol (CBD) from hemp and Tetrahydrocannabinol (THC) to be used for medicinal purpose, while focusing on pursuing business in the growing medical and recreational MJ sector. Through its acquired assets, NWPN is seeking to invest in its businesses associated with the growing, marketing, research and development, training, distribution and retail sale of scientific-grade medicinal canna, both in the United States and Canada.
Cannabis is expected to heavily disrupt the pharmaceutical industry as patients all over the world continue to report on the medicinal benefits of the all nat plant.
The US Congress is currently pushing through the H.R.841 Bill to make hemp, cannabidiol derived from hemp, and any other ingredient derived from hemp lawful for use under the Federal Food, Drug, and Cosmetic Act as a dietary ingredient in a dietary supplement, and for other purposes.
This may be the perfect time for you to start paying attention to this space and especially The Now Corporation (NWPN), which now has a proven history of making +520% moves.
The Now Corporation (NWPN) is dedicated to advancing the study
?of the medicinal use of Cannabidiol and other cannabinoids.
The Now Corporation seeks to develop canna-derived therapeutic products backed by scientific research.
The Now Corporation has developed, and will continue to form relationships, with world class research universities and institutions within the United States to perform collaborative CBD research.
Their commitment to further understanding the effects of cannabinoids upon psychiatric-related behavioral characteristics, cardiovascular physiology as well as digestive and metabolic systems will provide unprecedented insight into the effects of these naturally occurring substances upon human health and disease.
In an effort to uncover the potential therapeutic capacity of cannabinoids, The Now Corporation looks to establish the safest and most effective route of administration of highly purified CBD which currently remains to be determined within scientific literature.
Their ability to grow and analyze hemp seed genetic variability, the source of CBD, and its relationship to potency, will aid the pursuit of effective dosing that will be required for maximal health benefits.
The growing research and development and financial support for cannabinoid research, the incidence of chronic diseases and related complications, and the le·gal·iz·ation of CBD in different regions by various private and government organizations are expected to positively affect the global demand for cannabidiol (CBD).
Canna oil has become the new consumer trend due to the number of social media influencers endorsing the advantages of canna, awareness campaigns from industry participants, and application areas.
Plant-based medicine has experienced significant growth in recent years. The need for minimally formulated and chemical-free drugs has also opened up a lucrative opp·or·tun·ity to increase the market being examined.
The Now Corporation (NWPN) Signs A Memorandum Of Agreement
With Florida Agricultural & Mechanical University
The Now Corporation (NWPN) is pleased to announce that it has signed a Memorandum of Agreement with Florida Agricultural & Mechanical University (FAMU) to collaborate and participate in the research and development of scientifically researched cannabidiol products. Our ultimate goal is to develop cannabidiol products that can be used for the expressed purposes of developing medicinal products for human and animal use.
The Florida Agricultural and Mechanical University (FAMU) is an 1890 land-grant institution dedicated to the advancement of knowledge, resolution of complex issues and the empowerment of citizens and communities. The University provides a student-centered environment consistent with its core values. The faculty is committed to educating students at the undergraduate, graduate, doctoral and professional levels, preparing graduates to apply their knowledge, critical thinking skills and creativity in their service to society. FAMUs distinction as a doctoral/research institution will continue to provide mechanisms to address emerging issues through local and global partnerships.
Expanding upon the University’s land-grant status, it will enhance the lives of constituents through innovative research, engaging cooperative extension, and public service. While the University continues its historic mission of educating African Americans, FAMU embraces persons of all races, ethnic origins and nationalities as life-long members of the university community.
Ken Williams, CEO of The Now Corporation, states, it is an honor to have signed an agreement with FAMU last year. I applaud everything that the University stands for. I look forward to developing cannabidiol products that both parties can pro·fit from.
Dr. David Krolewski, Senior Scientific Advisor, said, this is exciting and a real game changer for our long-term goals. This wonderful collaboration is incredibly promising, but not just for what we set out to accomplish, this really opens so many more possibilities
Continued Research
As you continue your research on The Now Corporation (NWPN), you’ll discover that they purchased a large equity stake in TransGlobal Assets Inc. for their Monster Elixir Subsidiary.
Curtis Philpot, CEO of TransGlobal Assets Inc., has created a subsidiary called Monster Elixir Inc. which is extremely exciting as it will provide customers with a wide range of high-quality CBD products from its organically grown Indoor and Outdoor gardens. It uses some of the best genetics in the industry with a gua·ran·tee that its plants are free from all unwanted pests and harmful chemicals. Some other products are as follows.
Pur Root Lemonade: by utilizing the natural medicines in Marijuana Roots. Its Pur Root Lemonade will come in many flavors such as Ginger Bite and Pineapple Agave, sold in bulk or retail.
Infused Olive Oils: for all of your edible baking needs, it has Olive Oils Infused with CBDs, also sold in bulk or retail. Distillates by the cartridges: Indica, Sativa and hybrids will be available.
Plus, it will offer a unique arrangement of CBD Edibles, from hard candies and gummies to pound cakes and pies made from scratch.
These fine CBD products will be sold at local Dispensaries and other retail outlets, including at Monster Elixir stores coming soon.
It will be retaining a Cannabis Attorney to lobby its interests and to acquire the necessary licenses.
In addition, TransGlobal Assets Inc. owns two medical marijuana strains: Previously known as BB (Mob Boss x Rare Dankness #1) and MV (501st OG x Rare Dankness #1).
Ken Williams, CEO of The Now Corporation, states, it is a pleasure to purchase an equity stake in Curtiss’s company. He is a very knowledgeable young man that I have known for many years. I expect excellent returns for shareholders of both companies.
The relationship between Now Corporation (NWPN) and TransGlobal Assets Inc could prove to be extremely lucrative because of Congress's new Bill, H.R.841, making hemp and CBD legal as a dietary supplement at a Federal level.
This new Bill could open up a Huge Market for (NWPN) to expand their Drinks and CBD Edibles line.
Strong Management Team
Now Corporation (NWPN) is led by an extremely accomplished and talented Management Team.
Ken Williams
CEO and Managing Director
Ken Williams, CEO and Managing Director, also serves as Brand and Marketing Strategist. After spending five years leading public companies in the Le·g·al Marijuana Industry, three decades of Advanced Technology Engineering, and as an Executive for multimillion dollar brands, Ken knows what truly drives business. It’s how well you connect with the public to help and communicate for understanding. Ken has excellent strategic planning and corporate execution skills. He works with major financial providers and bank brokerage firms on strategic initiatives including planning, clearing decisions, corporate changes and providers, and executes on new business opp·or·tun·ities.
Juan Salazar
Chief Operating Officer
Juan Salazar, over the course of his career, has held senior and executive management positions with leading construction and development companies. He has a proven track record both at an operating and advisory level as a project manager, covering all stages of a construction from feasibility and engineering projects including technical reviews, project and financial evaluations to strategic planning, development, housing expansion, risk assessments and due diligence. Juan has extensive experience in agriculture and fish aquaponics forming a Florida-based corporation named Zorhek Aqua Farms in Miami, Florida.
David Krolewski, Ph.D.
Senior Corporate Research Advisor
David is a systems neuroscientist with a particular interest in neuroanatomical function pertaining to human health and disease. This arena of study allows for analysis of particular molecules that affect brain function in relation to behavioral outcomes. After receiving a B.S. from Grand Valley State University in Health Science, he worked as a research technician at the Ann Arbor Veteran’s hospital where he assessed neurotransmitter transporter abundance in the postmortem brain of people who died due to cocaine abuse. Following this experience, David went on to obtain a Ph.D. from Wayne State University Medical School where his research focused on Parkinson’s disease models and related neurocircuitry which regulate motor activity and its coordination.
David’s postdoctoral fellowship was completed at the University of Michigan Medical School and involved the investigation of neuronal gene expression in postmortem subjects previously diagnosed with psychiatric disorders including major depression, bipolar disorder, and schizophrenia. Advancing to a research faculty member at the University of Michigan Medical School, he co-instructed an undergraduate human neuroanatomy course and continued examining neurogenetic changes in psychiatric illness by optimizing cutting edge histological techniques to visualize and quantify molecular changes in 3-dimensional formats.
Jeffrey B. Martin
Chief Technology Officer
Jeff has 40 years of marketing, management and operational experience in a wide range of industries including management consulting, design engineering, environmental engineering and laboratory testing, and construction. He has held senior management positions in small private companies and large ($400 M+) publicly held enterprises. In addition to extensive marketing experience, Jeff has a background in all corporate administrative functions having managed human resources, IT, contracts, safety, heavy equipment, risk and procurement departments. He has also successfully integrated numerous companies resulting from acquisitions and mergers in both union and non-union environments. Jeff holds an MBA from Northwestern University and a BS in Electrical Engineering and an MS in Nuclear Engineering from the University of Illinois.
Brian Martin
Chief Innovation Officer
Brian has extensive experience in technology development, managing the implementation and operation of cutting-edge scientific technology in a research laboratory setting. His unique background as a research specialist has given him the technical expertise necessary for driving strategic innovation and identifying emerging market opp·or·tun·ities. Brian holds a Bachelor’s degree in Biochemistry and Molecular Biology with a focus on Biotechnology from Michigan State University.
Augustus Redmond
Director Of Business And Economic Development
Gus has over 35 years’ experience in Real Estate, Retailing, and Wholesale Industries. He has deep experience identifying and directing public/private joint ventures that are consistent with community objectives, including RFP solicitations, new initiatives, and revitalization efforts. He has extensive experience building rapport with businesses, property owners and real estate brokers. Gus has experience and background in Environmental Services including research, planning, and marketing of Wastewater, Solid Waste, and Hazardous Waste Recycling Systems for residential, commercial, and industrial applications.
Overview and Key Catalysts
Cannabis stocks have been rallying on the hopes of national le·gal·iz·ation in the U.S., a move that would be a major catalyst for companies in the industry.
The Barchart Technical Opinion Rating Issued
NWPN Bullish 100% "STRONG BUY"
Potential Catalyst for (NWPN): Wall Streets leading provider of market data to the global financial, media, and commodity industries Barchart.com just Rated The Now Corporation (NWPN) with a "SOLID" 11 BUY SIGNALS across the Short-Term Indicators, Medium-Term Indicators, Long-Term Indicators and the all-important Trend Indicator which could be signaling for a major breakout in the very near future - See Below
Investing.com Technical Opinion Rating Issued
NWPN Bullish STRONG BUY
?Potential Catalyst for (NWPN): Another bullish catalyst that points to a potential breakout is respected technical analysis site Investing.com. Their technical indicators triggered NWPN a STRONG BUY - See Below
NWPN Chart Looks to Be on The Verge Full-On Breakout
Signaling A Bullish Golden Cross
Potential Catalyst for (NWPN): Now if that doesn't excite you, maybe the fact that NWPN chart looks to be on the verge of a Full-on Breakout signaling a bullish golden cross.
NWPN RSI (Relative Strength Index) just crossed above 60 and could be indicating that a Bigger Breakout is Imminent.
Look at the chart below, you will see the 50 Day MA (blue line) moves up through the 200 Day MA (red line) - See Below
StockTA Technical Opinion Rating Issued
NWPN Very Bullish
Potential Catalyst for (NWPN): Another big catalyst that could be indicating that a Bigger Breakout is potentially Imminent is respected technical analysis site StockTA. Their technical indicators triggered NWPN Very Bullish - See Below
NWPN Multiple Bullish Catalysts Signaling
Breakout Gain Potential — +520% in Upside Potential
Potential Catalyst #1 for (NWPN): Congress Reintroduces Bill to Legalize CBD in Dietary Supplements. Legislation for a clear legal pathway to market hemp-derived CBD retains bipartisan support from lawmakers, applauded by industry trade groups and major retail and farm organizations. New Bill introduced by Congress a few days ago, H.R.841 to make Hemp and CBD le·g·al as a dietary supplement at a Federal level, could literally send shares of NWPN soaring as Congress is looking to fast-track Hemp and CBD through the FDA approval process.
Potential Catalyst #2 for (NWPN): The stock has a history of making +520% moves and could be setting up for an even bigger move to the upside. In the last 2 weeks, (NWPN) has jumped +252.27% when it breached its RSI level of 63.14 and ran from $.0088 to $.031. The stock just pulled back, consolidated, and could be setting up for an even bigger run.
Potential Catalyst #3 for (NWPN): The growing research and development and financial support for cannabinoid research, the incidence of chronic diseases and related complications, and the leg·al·ization of CBD in different regions by various private and government organizations are expected to positively affect the global demand for cannabidiol (CBD). It's estimated that the legal Cannabis industry could be worth $100BIL in the US alone by 2030.
Potential Catalyst #4 for (NWPN): Recession Proof. The cannabis industry's performance during the pandemic has lent credence to a growing notion within the industry that cannabis may be recession-proof and could be a boon to States with growing budget troubles. Cannabis businesses were deemed essential in most states where the drug is le·g·al. States that need to raise money to fund normal operations may look to Cannabis as a revenue source.
Potential Catalyst #5 for (NWPN): Possible Takeover Target? In the past few months, some big deals have taken place in the cannabis industry. In December 2020, there was news of a near-$4BIL merger including Canadian pot giants Aphria and Tilray, which will create the largest cannabis company in the world in terms of revenue. A few weeks ago, Jazz Pharmaceuticals also announced it would be acquiring GW Pharmaceuticals And with more states leg·al·izing marijuana and a slightly more pot-friendly presidential administration and U.S. Congress in place, there's tons of excitement in the industry right now.
Potential Catalyst #6 for (NWPN): Strong Management Team. The Now Corporation’s Management Team is led by CEO Ken Williams, just spent five years leading public companies in the Le·g·al Marijuana Industry and three decades of Advanced Technology Engineering. COO, Juan Salazar has a proven track record both at an operating and advisory level as a project manager, covering all stages of a construction from feasibility and engineering. The Senior Corporate Research Advisor is David Krolewski, Ph.D -- David is a systems neuroscientist with a particular interest in neuroanatomical function pertaining to human health and disease. This arena of study allows for analysis of particular molecules that affect brain function in relation to behavioral outcomes.
Potential Catalyst #7 for (NWPN): Wall Streets leading provider of market data to the global financial, media, and commodity industries Barchart.com just Rated The Now Corporation (NWPN) with a "SOLID" 11 BUY SIGNALS across the Short-Term Indicators, Medium-Term Indicators, Long-Term Indicators and the all-important Trend Indicator which could be signaling for a major breakout in the very near future.
Remember, NWPN has already made a +520% move since the beginning of 2021 and could be setting up for a much bigger move to the upside.
You need to add NWPN to the top of your watch list (first thing) Monday Morning.
I am urging all of our members to add NWPN to the top of your watch list right now, and be ready Monday morning at the opening bell!
Regards,
Editor In Chief, OTCtipReporter Investment Research
